MaxCyte, Inc. announced that Ron Holtz, who served as MaxCyte's CFO from 2005 until September 2020 and again since May 2022, having served as Chief Accounting Officer during the interim period, will take on the role of EVP, Administration for the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
348 GBX | -0.57% |
|
+16.00% | -1.28% |
Jul. 01 | MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 3000E Growth Index | CI |
Jul. 01 | MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 2000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.28% | 474M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte, Inc. Appoints Ron Holtz as EVP, Administration